Europe Neuropathic Pain Market Size & Outlook, 2026-2033
Related Markets
Europe neuropathic pain market highlights
- The Europe neuropathic pain market generated a revenue of USD 2,288.2 million in 2025.
- The market is expected to grow at a CAGR of 6.8% from 2026 to 2033.
- In terms of segment, anticonvulsants was the largest revenue generating drug type in 2025.
- Topical Agents is the most lucrative drug type segment registering the fastest growth during the forecast period.
- Country-wise, Norway is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 2,288.2 million |
| Market revenue in 2033 | USD 3,862.2 million |
| Growth rate | 6.8% (CAGR from 2026 to 2033) |
| Largest segment | Anticonvulsants |
| Fastest growing segment | Topical Agents |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Anticonvulsants, Antidepressants, Opioids, Topical Agents |
| Key market players worldwide | Pfizer Inc, Eli Lilly and Co, Johnson & Johnson, Novartis AG ADR, Viatris Inc, Teva Pharmaceutical Industries Ltd, AbbVie Inc, Grunenthal Pharma, Vertex Pharmaceuticals Inc, Daiichi Sankyo Co Ltd |
Other key industry trends
- In terms of revenue, Europe region accounted for 26.8% of the global neuropathic pain market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 4,349.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neuropathic Pain Market Scope
Neuropathic Pain Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Grunenthal Pharma | View profile | 101-250 | Humanes De Madrid, Madrid, Spain, Europe | https://www.grunenthal.es/ |
| Daiichi Sankyo Co Ltd | View profile | 17435 | 3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, Japan, 103-8426 | https://www.daiichisankyo.com |
| Vertex Pharmaceuticals Inc | View profile | 5400 | 50 Northern Avenue, Boston, MA, United States, 02210 | https://www.vrtx.com |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Europe neuropathic pain market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neuropathic pain market will help companies and investors design strategic landscapes.
Anticonvulsants was the largest segment with a revenue share of 42.53% in 2025. Horizon Databook has segmented the Europe neuropathic pain market based on anticonvulsants, antidepressants, opioids, topical agents covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Europe neuropathic pain market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe neuropathic pain market databook
-
Our clientele includes a mix of neuropathic pain market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe neuropathic pain market , including forecasts for subscribers. This continent databook contains high-level insights into Europe neuropathic pain market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Europe neuropathic pain market size, by country, 2021-2033 (US$M)
Europe Neuropathic Pain Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
